Document is current

Article History

First Online: 30 August 2016

Competing interests

: The Department of Intensive Care Medicine, Bern University Hospital, Switzerland (J.C.S.) has received research and development and/or consulting contracts from Orion Corporation, Abbott Nutrition International, B. Braun Medical AG, CSEM SA, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, Edwards Lifesciences SA, and Nestlé, for which no personal financial gain was received; educational grants from Fresenius Kabi; GSK; MSD; Lilly; Baxter; Astellas; AstraZeneca; B. Braun Medical AG, CSL Behring, Maquet, Novartis, Covidien, Nycomed, Pierre Fabre Pharma (Roba Pharma); Pfizer, Orion Pharma; J.C.S. has received research funding, (travel) grants, or speaker fees from Bayer AG/Schering AG, Eli Lilly, Anagnostics Bionanalysis GmbH/ Cube DX GesmbH, and Nestlé. G.F. is a member of committees of heart failure trials and registries sponsored by Novartis, Servier, Cardiorentis, Medtronic and Vifor. G.H. has consulted for Servier, Impulse Dynamics, Novartis, CircuLite, and DC Devices and received honoraria from CVRx, Impulse Dynamics, AstraZeneca, Bayer, and Orion. S.D.A. has consulted or received honoraria from Vifor, Novartis, Cardiorentis, Brahms, Bayer, Relypsa, ZS Pharma and Stealth Peptides. S.v.H. has received consultant honoraria, travel support, and/or speaker's fees from Vifor, Thermo Fisher Scientific, Respicardia, Sorin, Novartis, Chugai Pharma, AstraZeneca, Pfizer, Professional Dietetics and Solartium Dietetics.